Vivimed Labs Share PriceVivimed Labs

₹4.9
-0.1 (-2%)
As on 30 September, 2023 | 05:31 BSE: 532660 NSE: VIVIMEDLABISIN: INE526G01021

Vivimed Labs Performance

Day Range

  • Low 4.85
  • High 5.25
4.9

52 Week Range

  • Low 4.85
  • High 13.95
4.9
  • Open Price5.25
  • Previous Close5
  • Volume151690

Start SIP in Vivimed Labs

Start SIP

Vivimed Labs Share Price

  • Over 1 Month -14.04%
  • Over 3 Month -24.62%
  • Over 6 Month -50.25%
  • Over 1 Year -52.66%

Vivimed Labs Key Statistics

P/E Ratio -0.1
PEG Ratio 0
Market Cap Cr 41
Price to Book Ratio 1
EPS -39.6
Dividend 0
Relative Strength Index 16.76
Money Flow Index 11.32
MACD Signal -1.03
Average True Range 0.44

Vivimed Labs Investment Rating

  • Master Rating:
  • Vivimed Labs has an operating revenue of Rs. 172.34 Cr. on a trailing 12-month basis. An annual revenue de-growth of -21% needs improvement, Pre-tax margin of -177% needs improvement, ROE of -833% is poor and needs improvement. The company has a high debt to equity of 158%, which can be a reason to worry. From an O'Neil Methodology perspective, the stock has an EPS Rank of 17 which is a POOR score indicating inconsistency in earnings, a RS Rating of 2 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at E which indicates heavy supply, Group Rank of 111 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of E is the worst. Institutional holding has remained stable in the last reported quarter. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Vivimed Labs Financials
IndicatorJun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 334051394753
Operating Expenses Qtr Cr 3320357495655
Operating Profit Qtr Cr 0-164-6-10-9-2
Depreciation Qtr Cr 4954445
Interest Qtr Cr 11899910
Tax Qtr Cr 0-20003
Net Profit Qtr Cr -15-265-19-22-22-19
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 177220
Operating Expenses Annual Cr 365228
Operating Profit Annual in Cr -188-9
Depreciation Cr 10717
Interest Annual Cr 3540
Tax Annual Cr -23
Net Profit Annual Cr -328-68
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr 25
Cash from Investing Activity Annual Cr -11
Cash from Financing Annual Activity Cr -13
Net Cash Flow Annual Cr 1
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr 133457
Fixed Assets Annual Cr 364469
Total Non Current Assets Annual Cr 525630
Total Current Assets Annual Cr 268442
Total Assets Annual Cr 7921,072
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs 1655
ROE Annual % -246-16
ROCE Annual % -78-4
Total Debt to Total Equity Annual --
EBDIT Annual Margin % -106-4
IndicatorJun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 353756445061
Operating Expenses Qtr Cr 3620161545962
Operating Profit Qtr Cr 0-164-5-9-9-1
Depreciation Qtr Cr 5964445
Interest Qtr Cr 11999910
Tax Qtr Cr 0-20003
Net Profit Qtr Cr -16-266-18-22-22-18
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 188239
Operating Expenses Annual Cr 374245
Operating Profit Annual in Cr -187-8
Depreciation Cr 10818
Interest Annual Cr 3640
Tax Annual Cr -23
Net Profit Annual Cr -329-68
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr 28
Cash from Investing Activity Annual Cr -16
Cash from Financing Annual Activity Cr -10
Net Cash Flow Annual Cr 1
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr 39364
Fixed Assets Annual Cr 456543
Total Non Current Assets Annual Cr 656759
Total Current Assets Annual Cr 332507
Total Assets Annual Cr 9881,266
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs 544
ROE Annual % -833-21
ROCE Annual % -52-3
Total Debt to Total Equity Annual --
EBDIT Annual Margin % -100-3

Vivimed Labs Technicals

EMA & SMA

Current Price
₹4.9
-0.1 (-2%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • ₹6.14
  • 50 Day
  • ₹7.75
  • 100 Day
  • ₹8.95
  • 200 Day
  • ₹10.75
  • 20 Day
  • ₹5.94
  • 50 Day
  • ₹8.6
  • 100 Day
  • ₹9.31
  • 200 Day
  • ₹10.15

Vivimed Labs Resistance and Support

PIVOT
₹5.02
Resistance
First Resistance ₹5.19
Second Resistance ₹5.42
Third Resistance ₹5.59
RSI 16.77
MFI 11.32
MACD Single Line -1.03
MACD -0.98
Support
First Resistance ₹4.79
Second Resistance ₹4.62
Third Resistance ₹4.39

Vivimed Labs Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day
Week
1 Month
6 Month 25,668 2,566,785 100

Vivimed Labs Result Highlights

Vivimed Labs Synopsis

NSE-Medical-Diversified

Vivimed Labs is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 176.83 Cr. and Equity Capital is Rs. 16.58 Cr. for the Year ended 31/03/2023. Vivimed Labs Ltd. is a Public Limited Listed company incorporated on 22/09/1988 and has its registered office in the State of Karnataka, India. Company’s Corporate Identification Number(CIN) is L02411KA1988PLC009465 and registration number is 009465.
Market Cap 41
Sales 162
Shares in Float 6.55
No of funds 5
Yield
Book Value 0.31
U/D Vol ratio
LTDebt / Equity 46
Alpha -0.61
Beta -0.02

Vivimed Labs

Owner NameJun-23Mar-23Dec-22Sep-22
Promoters 20.94%20.94%20.96%20.96%
Foreign Portfolio Investors 1.64%1.64%1.64%1.64%
Individual Investors 57%57.08%57.03%57.64%
Others 20.42%20.34%20.37%19.76%

Vivimed Labs Management

Name Designation
Dr. Jamalapuram Harigopal Chairman & Ind.Director
Mr. Santosh Varalwar Managing Director
Dr. Manohar Rao Varalwar Whole Time Director
Mr. Sandeep Varalwar Whole Time Director
Mr. Subhash Varalwar Non Executive Director

Vivimed Labs Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Vivimed Labs Corporate Action

Date Purpose Remarks
2023-08-14 Quarterly Results
2023-05-30 Quarterly Results
2023-02-13 Quarterly Results
2023-01-13 A.G.M.
2022-08-12 Quarterly Results
  • Company Name
  • CMP
  • Chg(%)
  • Company Name
  • CMP
  • Chg(%)

Vivimed Labs FAQs

What is Share Price of Vivimed Labs ?

Vivimed Labs share price is ₹4 As on 30 September, 2023 | 05:17

What is the Market Cap of Vivimed Labs ?

The Market Cap of Vivimed Labs is ₹40.6 Cr As on 30 September, 2023 | 05:17

What is the P/E ratio of Vivimed Labs ?

The P/E ratio of Vivimed Labs is -0.1 As on 30 September, 2023 | 05:17

What is the PB ratio of Vivimed Labs ?

The PB ratio of Vivimed Labs is 1 As on 30 September, 2023 | 05:17

Q2FY23